Major cardiovascular events and associated factors among routine hemodialysis patients with end-stage renal disease at tertiary care hospital in Somalia

被引:4
作者
Mohamud, Mohamed Farah Yusuf [1 ]
Nur Adan, Faduma [1 ]
Jeele, Mohamed Osman Omar [1 ]
Ahmed, Mohamed A. M. [2 ]
机构
[1] Mogadishu Somali Turkish Training & Res Hosp, Mogadishu, Somalia
[2] Mogadishu Univ, Dept Pediat, Mogadishu, Somalia
关键词
hemodialysis; end-stage renal disease; cardiovascular disease; heart failure; diabetic; hypertension; CHRONIC KIDNEY-DISEASE; COMPLICATIONS; PREDICTOR;
D O I
10.3389/fmed.2023.1086359
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
IntroductionCardiovascular complications are the most significant cause of death in patients undergoing routine hemodialysi (HD) with end-stage renal disease (ESRD). The main objective of this study is to determine the significant cardiac events and risk factors in patients undergoing routine hemodialysis in Somalia. MethodsWe carried out a cross-sectional retrospective study in a single dialysis center in Somalia. Two hundred out of 224 were included. All of them had ESRD and were on hemodialysis during the study period between May and October 2021. The records of all patients were reviewed, and the following parameters were analyzed socio-demographic factors, risk factors for cardiovascular disease, and the presence of cardiovascular diseases. ResultsThe mean age was 54 +/- 17.5 years (range 18-88 years), and 106 (53%) patients were males. The prevalence of a cardiovascular disease among hemodialysis patients was 29.5%. Moreover, the distribution of cardiovascular diseases was different; heart failure was the most common, about 27.1%, followed by coronary artery disease (17%), pericarditis and pericardial-effusion (13.6%), dysrhythmia (10.2%), cerebrovascular-accident (8.5%), and peripheral vascular disease (3.4%). About 176 (88%) participants had at least one modifiable cardiovascular risk factor. The most common modifiable cardiovascular risk factor was hypertension (n = 45, 25.1%), followed by anemia (n = 28, 15.6%) and diabetes (n = 26, 14.5%). Younger (18-30) participants were six times less likely to have cardiovascular events among hemodialysis than older age 0.4 (0.11-1.12). ConclusionLow prevalence rate of cardiovascular complications was confirmed in ESRD patients receiving hemodialysis in the main HD center in Somalia. Diabetes, anemia, and hypertension were the highest significant risk factors for CVD in HD patients with ESRD in Somalia.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] Intensive hemodialysis for cardiomyopathy associated with end-stage renal disease
    Nehus, Edward
    Goebel, Jens
    Mitsnefes, Mark
    Lorts, Angela
    Laskin, Benjamin
    [J]. PEDIATRIC NEPHROLOGY, 2011, 26 (10) : 1909 - 1912
  • [32] Hypertension and Future Cardiovascular Health in Pediatric End-Stage Renal Disease Patients
    Flynn, Joseph T.
    [J]. BLOOD PURIFICATION, 2012, 33 (1-3) : 138 - 143
  • [33] Intensive hemodialysis for cardiomyopathy associated with end-stage renal disease
    Edward Nehus
    Jens Goebel
    Mark Mitsnefes
    Angela Lorts
    Benjamin Laskin
    [J]. Pediatric Nephrology, 2011, 26 : 1909 - 1912
  • [34] Eicosapentaenoic Acid as a Potential Therapeutic Approach to Reduce Cardiovascular Risk in Patients with End-Stage Renal Disease on Hemodialysis: A Review
    Borow, Kenneth M.
    Mason, R. Preston
    Vijayaraghavan, Krishnaswami
    [J]. CARDIORENAL MEDICINE, 2018, 8 (01) : 18 - 30
  • [35] Risk Factors for Temporary Vascular Access Infection in Patients with End-Stage Renal Disease Undergoing Hemodialysis in Cipto Mangunkusumo Hospital
    Susilo, Adityo
    Suryana, Kresna Dharma
    Nugroho, Pringgodigdo
    Alodia, Beryl
    Nainggolan, Leonard
    Nainggolan, Leonard
    [J]. ACTA MEDICA INDONESIANA, 2022, 54 (03) : 356 - 364
  • [36] Effects of Lipid-Lowering Therapy on Reduction of Cardiovascular Events in Patients with End-Stage Renal Disease Requiring Hemodialysis
    Marrs, Joel C.
    Saseen, Joseph J.
    [J]. PHARMACOTHERAPY, 2010, 30 (08): : 823 - 829
  • [37] Thyroid Pathology in End-Stage Renal Disease Patients on Hemodialysis
    Cotoi, Laura
    Borcan, Florin
    Sporea, Ioan
    Amzar, Daniela
    Schiller, Oana
    Schiller, Adalbert
    Dehelean, Cristina A.
    Pop, Gheorghe Nicusor
    Borlea, Andreea
    Stoian, Dana
    [J]. DIAGNOSTICS, 2020, 10 (04)
  • [38] Cutaneous manifestations in patients with end-stage renal disease on hemodialysis
    Kebria, Azar Shirzadian
    Aryanian, Zeinab
    Choobdar, Amin
    Akbari, Roghayeh
    [J]. CASPIAN JOURNAL OF INTERNAL MEDICINE, 2023, 14 (04) : 728 - 731
  • [39] Prevalence and Risk Factors of Osteoporosis in Saudi End-stage Renal Disease Patients on Hemodialysis
    Mahzari, Moeber M.
    Alibrahim, Ahmed R.
    Alghamdi, Nawaf A.
    Alsadhan, Muatassem A.
    Almoamary, Saad M.
    Masuadi, Emad M.
    Al Shahrani, Awad S.
    [J]. SAUDI JOURNAL OF MEDICINE & MEDICAL SCIENCES, 2022, 10 (03): : 259 - +
  • [40] Myocardial microvascular disease and major adverse cardiovascular events in patients with end-stage renal disease: rationale and design of the MICROCARD study
    Bejan-Angoulvant, Theodora
    Bergerot, Cyrille
    Juillard, Laurent
    Mezergues, Aline
    Morelon, Emmanuel
    Pouteil-Noble, Claire
    Andre-Fouet, Xavier
    Angoulvant, Denis
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 (07) : 2886 - 2891